Literature DB >> 35342480

Proteomics of Tear in Inactive Thyroid-Associated Ophthalmopathy.

L Jiang1, R Wei1, J Diao1, H Ding1, W Wang1, R Ao1.   

Abstract

Background: Thyroid-associated ophthalmopathy (TAO), one of the most common orbital diseases in adults, seriously reduces patients' quality of life. Although human tear proteomics identified many abnormal expressed proteins and proposed several pathogeneses of TAO, most of these studies focused on the active stage or mixed types in TAO. In this study we identified significantly changed proteins and preliminary revealed the potential signalling pathways and mechanisms of TAO with the late, inactive stage. Patients and
Methods: Tears from TAO patients (n=6) with a CAS score < 3 and 6 control healthy subject were collected. The pooled tears were further fractionated using high pH reversed-phase chromatography, then submitted to LC-MS/MS and subsequent bioinformatic analysis.
Results: Proteomic profiling identified 107 significantly changed proteins between the inactive stage of TAO patients and healthy cases. Among these proteins, 62 were upregulated, and 45 were downregulated in TAO cases compared to healthy individuals. Enrichment analysis revealed that the immune system, cell cycle, metabolism (carbohydrate metabolism and metabolism of cofactors and vitamins), protein synthesis and degradation might play a vital role in the progress of inactive TAO. The present investigation represents the first proteomic tear study of TAO patients in the inactive stage.
Conclusion: The results shed light on the differences between inactive TAO patients and healthy cases, thus enabling us to understand better the molecular mechanisms and potential targets for the treatment of inactive TAO. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Bioinformatics; Inactive stage; Tear proteomics; Thyroid-associated ophthalmopathy

Year:  2021        PMID: 35342480      PMCID: PMC8919484          DOI: 10.4183/aeb.2021.291

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  28 in total

1.  The tear cytokine profile in patients with active Graves' orbitopathy.

Authors:  Morgan Yang; Yvonne Chung; Stephanie Lang; Nobuyo Yawata; Lay Leng Seah; Audrey Looi
Journal:  Endocrine       Date:  2017-11-16       Impact factor: 3.633

2.  Teprotumumab for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; George J Kahaly; Daniel G Ezra; James C Fleming; Roger A Dailey; Rosa A Tang; Gerald J Harris; Alessandro Antonelli; Mario Salvi; Robert A Goldberg; James W Gigantelli; Steven M Couch; Erin M Shriver; Brent R Hayek; Eric M Hink; Richard M Woodward; Kathleen Gabriel; Guido Magni; Raymond S Douglas
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

3.  Latent Pathways Identification by Microarray Expression Profiles in Thyroid-Associated Ophthalmopathy Patients.

Authors:  Pingqian Zhao; Haitao Yin; Chen Tao; Ping Chen; Ying Song; Wenlei Yang; Lin Liu
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

4.  Analysis of Graves' ophthalmopathy patients' tear protein spectrum.

Authors:  Li-hong Jiang; Rui-li Wei
Journal:  Chin Med J (Engl)       Date:  2013-12       Impact factor: 2.628

5.  Circulating Levels of Orexin-A, Nesfatin-1, Agouti-Related Peptide, and Neuropeptide Y in Patients with Hyperthyroidism.

Authors:  Yusuf Tohma; Mujde Akturk; Alev Altinova; Emine Yassibas; Ethem Turgay Cerit; Ozlem Gulbahar; Metin Arslan; Nevin Sanlier; Fusun Toruner
Journal:  Thyroid       Date:  2015-05-19       Impact factor: 6.568

6.  Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients?

Authors:  Ji Won Kim; Young Jun Woo; Jin Sook Yoon
Journal:  Endocr J       Date:  2016-09-13       Impact factor: 2.349

Review 7.  Excess thyroid hormone and carbohydrate metabolism.

Authors:  Matthew Potenza; Michael A Via; Robert T Yanagisawa
Journal:  Endocr Pract       Date:  2009-04       Impact factor: 3.443

Review 8.  Thyroid hormone signaling in energy homeostasis and energy metabolism.

Authors:  Elizabeth A McAninch; Antonio C Bianco
Journal:  Ann N Y Acad Sci       Date:  2014-02-20       Impact factor: 5.691

9.  Defining the proteome of human iris, ciliary body, retinal pigment epithelium, and choroid.

Authors:  Pingbo Zhang; David Kirby; Craig Dufresne; Yan Chen; Randi Turner; Sara Ferri; Deepak P Edward; Jennifer E Van Eyk; Richard D Semba
Journal:  Proteomics       Date:  2016-03-11       Impact factor: 3.984

10.  Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score.

Authors:  Won Choi; Ying Li; Yong Sok Ji; Kyung Chul Yoon
Journal:  BMC Ophthalmol       Date:  2018-11-21       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.